ICM
CX icon

Invenomic Capital Management’s Cemex CX Stock Holding History

Invenomic Capital Management’s Portfolio CX Stock Details CX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-117,805
Closed -$821K – 130
2021
Q1 		$821K Buy
117,805
+23,548
+25% +$152K 0.18% 90
2020
Q4 		$487K Sell
94,257
-31,609
-25% -$145K 0.12% 99
2020
Q3 		$479K Sell
125,866
-27,495
-18% -$89.9K 0.26% 93
2020
Q2 		$442K Hold
153,361
– – 0.33% 91
2020
Q1 		$325K Buy
153,361
+46,951
+44% +$159K 0.27% 95
2019
Q4 		$403K Buy
+106,410
New +$405K 0.16% 100

Other funds holding CX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
RAA
RWC Asset Advisors Miami, Florida $464M AUM 93.73% 1-Year Est. Return
TIAM
TT International Asset Management London, United Kingdom $783M AUM 104.75% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Invenomic Capital Management's CX Position: Q2 2021 in Review

Invenomic Capital Management sold out of Cemex (CX) in Q2 2021, closing a stake of 117,805 shares — an estimated $821K sold.

Invenomic Capital Management first reported a position in CX in Q4 2019 and held it in 6 quarters. The position peaked at $821K in Q1 2021. 286 funds tracked by Wall St. Rank hold CX as of Q2 2021.

  • Invenomic Capital Management reported no remaining Cemex position as of Q2 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 117,805 Cemex shares in Q2 2021, an estimated $821K.
  • Invenomic Capital Management first reported a position in Cemex in Q4 2019 and held it in 6 quarters.
  • Invenomic Capital Management's Cemex position peaked at $821K in Q1 2021.
  • 286 funds tracked by Wall St. Rank held Cemex as of Q2 2021.

Based on Invenomic Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.